Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Jun 1;153(6):1474–1488. doi: 10.1084/jem.153.6.1474

Capacity of genetically different T lymphocytes to induce lethal graft- versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft- versus-host disease

PMCID: PMC2186178  PMID: 6454750

Abstract

When comparing, in a murine model, the kind of graft-versus-host (GVH) disease (GVHD) induced by the donor strain DBA/2 on the one hand and several H-2-congenic resistant B10 donor strains on the other, we found that strain DBA/2 was a universal nonkilling GVH donor for H-2- incompatible nonirradiated F1 hybrid recipients. In this respect, DBA/2 T cells differed from those of the H-2-identical donor strain B10.D2 as well as those of other b10 donor strains. The inability of strain DBA/2 to kill by GVH reaction was not limited to certain H-2 incompatibilities in the F1 recipients, but was nonspecific. The inability to kill is determined by a dominant locus not linked to H-2. DBA/2 T cells were also incapable of inducing the severe suppression of hematocrit values, bone marrow erythropoiesis, thymic cell proliferation, and splenic IgG production in the F1 recipients that was observed after the injection of T cell from the B10 strains. However, DBA/2 T cells, in contrast with those of the B10 donor strains, were vigorous stimulators of IgG production in H-2-incompatible F1 hybrid recipients. Surprisingly, strain DBA/2 as well as the B10 donor strains had good capacity to generate anti-F1 TK cells. Taken together, these findings raise the possibility that lethal GVHD disease is not caused, or not caused exclusively, by donor killer T cells, but by those donor T cells that directly or indirectly induce a suppression of cell proliferation in certain vital organs of the recipient.

Full Text

The Full Text of this article is available as a PDF (922.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascensão J., Pahwa R., Kagan W., Hansen J., Moore M., Good R. Aplastic anaemia: Evidence for an immunological mechanism. Lancet. 1976 Mar 27;1(7961):669–671. doi: 10.1016/s0140-6736(76)92780-x. [DOI] [PubMed] [Google Scholar]
  2. Cantor H., Gershon R. K. Immunological circuits: cellular composition. Fed Proc. 1979 Jun;38(7):2058–2064. [PubMed] [Google Scholar]
  3. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  4. Drell D. W., Wegmann T. G. The genetics of tolerance induction in histoincompatible parabiosed mice. Transplant Proc. 1976 Sep;8(3):363–367. [PubMed] [Google Scholar]
  5. Elkins W. L. Cellular immunology and the pathogenesis of graft versus host reactions. Prog Allergy. 1971;15:78–187. [PubMed] [Google Scholar]
  6. Elkins W. L. Correlation of graft-versus-host mortality and positive CML assay in the mouse. Transplant Proc. 1976 Sep;8(3):343–347. [PubMed] [Google Scholar]
  7. Farrar J. J., Loughman B. E., Nordin A. A. Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and aged mice. J Immunol. 1974 Mar;112(3):1244–1249. [PubMed] [Google Scholar]
  8. Fialkow P. J., Gilchrist C., Allison A. C. Autoimmunity in chronic graft-versus-host disease. Clin Exp Immunol. 1973 Apr;13(4):479–486. [PMC free article] [PubMed] [Google Scholar]
  9. Gleichmann E., Gleichmann H., Schwartz R. S. Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. J Natl Cancer Inst. 1972 Sep;49(3):793–804. [PubMed] [Google Scholar]
  10. Gleichmann E., Gleichmann H., Wilke W. Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev. 1976;31:156–224. doi: 10.1111/j.1600-065x.1976.tb01454.x. [DOI] [PubMed] [Google Scholar]
  11. Gleichmann H., Gleichmann E., André-Schwartz J., Schwartz R. S. Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med. 1972 Mar 1;135(3):516–532. doi: 10.1084/jem.135.3.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoffman R., Zanjani E. D., Lutton J. D., Zalusky R., Wasserman L. R. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med. 1977 Jan 6;296(1):10–13. doi: 10.1056/NEJM197701062960103. [DOI] [PubMed] [Google Scholar]
  13. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  14. Korngold R., Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med. 1978 Dec 1;148(6):1687–1698. doi: 10.1084/jem.148.6.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lawrence W., Jr, Simonsen M. The property of "strength" of histocompatibility antigens, and their ability to produce antigenic competition. Transplantation. 1967 Sep 5;5(5):1304–1322. doi: 10.1097/00007890-196709000-00009. [DOI] [PubMed] [Google Scholar]
  16. Lindholm L., Rydberg L., Strannegård O. Development of host plasma cells during graft-versus-host reactions in mice. Eur J Immunol. 1973 Aug;3(8):511–515. doi: 10.1002/eji.1830030812. [DOI] [PubMed] [Google Scholar]
  17. Perren B., Schumann G., Gisler R. H., Dukor P. Dissociation of cytotoxicity and helper activity of irradiated thymus cells. Transplantation. 1974 Apr;17(4):392–399. doi: 10.1097/00007890-197404000-00009. [DOI] [PubMed] [Google Scholar]
  18. Pickel K., Hoffmann M. K. Suppressor T cells arising in mice undergoing a graft-vs-host response. J Immunol. 1977 Feb;118(2):653–656. [PubMed] [Google Scholar]
  19. Pinno E., Bain G. O., Campbell L. A. Erythropoietic shifts in the graft vs host reaction. Arch Pathol. 1969 Sep;88(3):284–293. [PubMed] [Google Scholar]
  20. Raff M. C., Owen J. J. Thymus-derived lymphocytes: their distribution and role in the development of peripheral lymphoid tissues of the mouse. Eur J Immunol. 1971 Jan;1(1):27–30. doi: 10.1002/eji.1830010105. [DOI] [PubMed] [Google Scholar]
  21. Rappaport H., Khalil A., Halle-Pannenko O., Pritchard L., Dantchev D., Mathé G. Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Am J Pathol. 1979 Jul;96(1):121–142. [PMC free article] [PubMed] [Google Scholar]
  22. Seemayer T. A., Lapp W. S., Bolande R. P. Thymic involution in murine graft-versus-host reaction. Epithelial injury mimicking human thymic dysplasia. Am J Pathol. 1977 Jul;88(1):119–134. [PMC free article] [PubMed] [Google Scholar]
  23. Sekiguchi M., Fujii G., Sude K., Suzuki K. Failure to produce graft versus host reaction with splenic cells from athymic nude mice. Jpn J Exp Med. 1977 Dec;47(6):531–533. [PubMed] [Google Scholar]
  24. Shand F. L. Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action. Immunology. 1976 Dec;31(6):943–951. [PMC free article] [PubMed] [Google Scholar]
  25. Sprent J., Miller J. F. Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells. Cell Immunol. 1972 Feb;3(2):213–230. doi: 10.1016/0008-8749(72)90161-x. [DOI] [PubMed] [Google Scholar]
  26. van Bekkum D. W., Roodenburg J., Heidt P. J., van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst. 1974 Feb;52(2):401–404. doi: 10.1093/jnci/52.2.401. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES